Purpose: To evaluate distance, intermediate, and near vision after bilateral implantation of a diffractive aspheric trifocal intraocular lens (IOL). Methods: This study enrolled 204 eyes of 102 patients who had bilateral implantation of the AT LISA tri 839MP IOL. Monocular and binocular uncorrected distance visual acuity (UDVA) and corrected distance visual acuity (CDVA) (4 meters), monocular and binocular uncorrected near visual acuity (UNVA) and distance-corrected near visual acuity (DCNVA) (30, 40 centimeters), binocular uncorrected intermediate visual acuity (UIVA) and distancecorrected intermediate visual acuity (DCIVA) (50, 60, 70 centimeters), the defocus curve, and binocular photopic and mesopic contrast sensitivity with and without glare were evaluated over 6 months. Results: No statistically significant differences in visual acuity outcomes between follow-up visits were found at any distance evaluated (p>0.05). Six months postoperatively, the mean monocular UDVA and UNVA were comparable to preoperative CDVA and DCNVA, respectively. All patients achieved a binocular CDVA of 20/25 or better. The mean binocular DCIVA ranged from 0.11 ± 0.11 (70 cm) to 0.07 ± 0.11 logMAR (50 cm). The mean binocular DCNVA was 20/25 or better in nearly 87% of patients. The defocus curve showed a wide range of useful vision, with no statistically significant differences in visual acuity at intermediate distances (p = 0.151). Mesopic contrast sensitivity was lower than under photopic conditions, particularly at medium and high spatial frequencies (p<0.001). Conclusions: Bilateral implantation of this trifocal IOL provides good visual outcomes at far, intermediate, and near distances, being an effective solution to reduce spectacle dependence after lensectomy.
Original article
Besides far and near vision, the achievement of a functional intermediate vision after cataract surgery is also crucial for patients with presbyopia; for example, for tasks related to computer use. In this sense, new IOL designs providing 3 main foci-devoted to far, intermediate, and near vision-have been developed (19) (20) (21) . The AT LISA tri 839MP IOL (Carl Zeiss Meditec, Jena, Germany) uses this trifocal design in the center of the IOL with a conventional bifocal diffractive pattern on the periphery. To date, there are few clinical studies assessing visual performance after implantation of this new trifocal IOL (22) (23) (24) (25) . A comparative study by Mojzis et al (22) showed significantly better intermediate vision provided by the AT LISA tri 839MP IOL over its bifocal predecessor with equivalent postoperative levels of visual and ocular optical quality. Mojzis et al (23) and Law et al (24) reported excellent distance, intermediate, and near visual outcomes with high levels of patient satisfaction through the first months following surgery. These results agree with those reported by Marques and Ferreira (25) in a recent study. However, all studies enrolled a small series of 15 to 30 patients in which the trifocal IOL was implanted.
Introduction
Multifocal intraocular lenses (IOLs) have been introduced into clinical practice as an optical solution to satisfy the visual demands of presbyopic patients who wish to be spectacle independent. In recent years, many studies have demonstrated that refractive (1) (2) (3) (4) , diffractive (5) (6) (7) (8) (9) , and hybrid (10) (11) (12) (13) (14) IOLs provide good distance and near vision when implanted. However, the visual function at intermediate distance in patients with these bifocal IOLs has been shown to be somewhat poorer compared with that at far and near distances (15) (16) (17) (18) .
The aim of the present study was to assess distance, intermediate, and near visual acuities and distance contrast sensitivity under photopic and mesopic conditions in a larger sample of patients who had bilateral implantation of the AT LISA tri 839MP IOL after lensectomy.
Methods
This prospective study comprised patients who had lensectomy with the bilateral implantation of the AT LISA tri 839MP trifocal IOL at the Fernández-Vega Ophthalmological Institute, Oviedo, Spain. The research was performed in accordance with the tenets of the Declaration of Helsinki and was approved by an institutional review board. Informed consent was obtained from all patients after receiving a full explanation of the nature and possible consequences of the study.
Inclusion criteria were age between 43 and 75 years, bilateral IOL implantation, and the common desire to achieve spectacle or contact lens independence for any working distance. Exclusion criteria included corneal astigmatism of 1.50 D or higher, history of glaucoma or retinal detachment, corneal disease, previous corneal or intraocular surgery, abnormal iris, pupil deformation, macular degeneration or retinopathy, neuro-ophthalmic disease, and history of ocular inflammation.
Preoperative assessment
Before surgery, all patients had a complete ophthalmologic examination including manifest refraction, keratometry, slit-lamp biomicroscopy, Goldmann applanation tonometry, and binocular indirect ophthalmoscopy through dilated pupils. Axial length and anterior segment size were measured with a noncontact optical biometer (IOLMaster; Carl Zeiss Meditec). Pupil diameter with distance vision was measured at 2 different levels of illumination using a pupillometer (Colvard; Oasis, San Dimas, CA).
Intraocular lens
The AT LISA tri 839MP is a single-piece aspheric diffractive multifocal IOL with a 6.0-mm biconvex optic, an overall diameter of 11.0 mm, and 0-degree haptic angulation. The optic design of the IOL combines a central trifocal zone of 4.34 mm diameter with a bifocal zone on the periphery from 4.34 to 6.0 mm. In the central zone, the AT LISA tri 839MP IOL provides a near addition of +3.33 D and an intermediate addition of +1.66 D at the IOL plane. The incident light is distributed asymmetrically with 50%, 20%, and 30% to distance, intermediate, and near foci, respectively. The IOL has an aspheric profile to correct positive spherical aberration of the cornea. The optic is made of foldable hydrophilic acrylate (refractive index 1.46) with 25% water content and hydrophobic surface properties. The hydrophobic surface of the lens has a 360-degree square edge to reduce posterior capsule opacification. The IOL power varies from 0.00 to +32.00 D in 0.50 D steps.
Surgical technique
The same experienced surgeon (J.F.A.) performed all surgeries. The technique included topical anesthesia, a 2.2-mm clear corneal microincision, capsulorhexis creation, and phacoemulsification (Infiniti Vision System; Alcon Laboratories, Fort Worth, TX). Phacoemulsification was followed by irrigation and aspiration of the cortex and implantation of the AT LISA tri 839MP trifocal IOL in the capsular bag using the Bluemixs 180 injector (Carl Zeiss Meditec). Postoperative topical therapy including anti-inflammatory and antibiotic medications was used for 4 weeks. The time between the 2 surgeries was 7 days.
Postoperative assessment
Postoperative follow-up visits were scheduled at 1 day, 1 week, and 1, 3, and 6 months. The standard ophthalmologic examinations included manifest refraction, visual performance, slit-lamp biomicroscopy, Goldmann applanation tonometry, and binocular indirect ophthalmoscopy through dilated pupils. Intraocular lens tilt and centration were assessed using a Scheimpflug videophotography system (EAS-1000; Nidek, Aichi, Japan).
Visual acuity (VA) measurements were performed under photopic conditions (85 candelas [cd]/m 2 ). Monocular and binocular uncorrected distance VA (UDVA) and corrected distance VA (CDVA) were measured at 100% contrast using Early Treatment of Diabetic Retinopathy Study (ETDRS) charts (Optec 6500; Stereo Optical Co., Chicago, IL) at 4 meters. Monocular and binocular uncorrected near VA (UNVA) and distance-corrected near VA (DCNVA) were measured using the Logarithmic Visual Acuity Chart 2000 New ETDRS (Precision Vision, Lasalle, IL) at 30 centimeters and 40 centimeters. Intermediate VA was assessed under binocular conditions. Binocular uncorrected intermediate VA (UIVA) and distancecorrected intermediate VA (DCIVA) were measured at 50 centimeters, 60 centimeters, and 70 centimeters with the same test used for near assessment but with an adjustment for distance. Through-focus binocular logMAR acuity (defocus curve) was measured 6 months after surgery to characterize the far, near, and intermediate visual function. Patients observed a distance logMAR chart through pairs of negative lenses increasing from +2.00 to -5.00 D in 0.50 D steps.
Binocular photopic (85 cd/m 2 ) and mesopic (3 cd/m 2 ) contrast sensitivity with and without glare were measured with distance correction at spatial frequencies of 1.5, 3, 6, 12, and 18 cycles per degree using the functional acuity contrast test (Stereo Optical Co.) 6 months postoperatively. Before mesopic contrast sensitivity testing, patients remained 10 minutes inside the testing room under mesopic conditions in order to allow adaptation to the luminance conditions. Absolute log 10 contrast sensitivity (log 10 CS) values were obtained for each combination of patient, spatial frequency, and luminance, and the mean values and standard deviations were calculated. All examinations were performed by the same ophthalmic technician, who was unaware of the objective of the study.
Statistical analysis
Data analysis was performed using SigmaPlot v12 software (Systat Software, San Jose, CA, USA). Normality was checked by the Shapiro-Wilk test. Statistical differences in visual outcomes between preoperative and 6 months postoperative were analyzed with the nonparametric Mann-Whitney U test.
The Friedman repeated measures analysis of variance on ranks test was used to evaluate differences in VA between followup visits and in contrast sensitivity under different luminance conditions. The multiple comparison post hoc Tukey test was performed when differences were found. The Kruskal-Wallis test was used to evaluate differences in VA in the intermediate distance range. Data are reported as mean ± SD. Differences were considered statistically significant when the p value was less than 0.05.
Results
The study evaluated a total of 204 eyes of 102 patients (67 women, 35 men). The mean age was 60.5 ± 8.5 years (range 43-75 years). Table I shows patient demographics. There were no intraoperative complications in any case. After the surgery and multifocal IOL implantation, all patients had round pupils with no iris trauma and showed good responsiveness to light. All IOLs were well-centered and were not tilted. Figure 1 shows the mean monocular VA for far and near vision (40 cm) preoperatively and 6 months after multifocal IOL implantation. Regarding far vision, the mean postoperative monocular UDVA was comparable to preoperative monocular CDVA. When the postoperative residual refractive error was corrected (Tab. I), the mean monocular UDVA improved from 0.11 ± 0.16 logMAR (approximately 20/25) to 0.05 ± 0.10 logMAR (>20/25). At 6 months, the mean monocular CDVA was statistically significantly better than preoperatively (p = 0.002). Regarding near vision, the mean postoperative monocular UNVA was 0.17 ± 0.13 logMAR (about 20/32), which improved slightly to 0.14 ± 0.12 logMAR (approximately 20/25) with best distance correction. The mean postoperative monocular DCNVA was somewhat better than preoperatively; no statistical significance was found with respect to preoperative data (p = 0.835). Table II summarizes the mean binocular distance, intermediate, and near visual acuities and the percentage of eyes having 20/40 or better acuity and 20/25 or better acuity at each distance over the 6-month follow-up. No statistically significant differences in VA (uncorrected and corrected) outcomes between follow-up visits were found at any distance evaluated (p>0.05). Six months after multifocal IOL implantation, all patients achieved a binocular CDVA of 20/25 or better. The mean binocular UIVA and DCIVA ranged from 0.12 ± 0.11 and 0.11 ± 0.11 logMAR (approximately 20/25) at 70 cm to 0.08 ± 0.11 and 0.07 ± 0.11 logMAR (>20/25) at 50 cm, respectively. The fewest patients achieved an acuity of 20/25 or better (uncorrected and corrected) at 60 cm distance. The mean binocular CNVA was 0.31 ± 0.12 logMAR (about 20/40) at 30 cm and 0.06 ± 0.10 logMAR (>20/25) when measured at 40 cm, with approximately 87% of patients achieving 20/25 or better acuity. Figure 2 shows the through-focus best corrected binocular logMAR VA at 6 months. As can be seen, the maximum value of VA was obtained at a vergence of 0.00 D, corresponding to the far focus. A second peak was found at approximately -2.00 D to -2.50 D defocus, corresponding to the near focus. Between these main foci, the curve showed a wide range of useful vision with VA values of 0.2 logMAR or better, corresponding to the intermediate focus. No statistically significant differences in VA outcomes in the range between -2.00 and -1.00 D (equivalent to 50 cm and 1 m, respectively) were found (p = 0.151). Figure 3 shows the mean binocular log 10 CS values under photopic (85 cd/m 2 ) and mesopic (3 cd/m 2 ) conditions with and without glare 6 months postoperatively. The values are plotted as a series of contrast sensitivity functions at these 2 illumination levels. Contrast sensitivity under mesopic conditions with and without glare was lower than under photopic conditions at all spatial frequencies analyzed. Differences between the 2 lighting conditions were statistically significant at medium and high spatial frequencies (p<0.001). There were no significant differences between contrast sensitivity under mesopic conditions with and without glare (p>0.05).
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Discussion
Multifocal IOLs using a trifocal design have been developed recently with the intention of improving intermediate vision related to many daily activities (e.g., the use of computers). The AT LISA tri 839MP IOL is based on this concept, combining a central trifocal zone that provides an addition of +3.33 D and +1.66 D for near and intermediate distances, respectively, with a bifocal diffractive pattern on the periphery. Previous clinical studies have reported the initial outcomes after implantation of this new trifocal IOL (22) (23) (24) (25) . However, all studies were focused on the short-term visual outcomes obtained in a small sample of patients after 3 to 6 months. The aim of the present study was to confirm the good results in terms of VA for different distances and contrast sensitivity provided by the AT LISA tri 839MP IOL in a larger sample of patients (204 eyes of 102 patients). To our knowledge, this represents the largest cohort evaluated after bilateral implantation of this trifocal IOL following lensectomy.
We found stable VA outcomes, with no statistically significant differences between follow-up visits. Six months post-operatively, the mean monocular UDVA and CDVA were 0.11 ± 0.16 and 0.05 ± 0.10 logMAR, respectively, with 100% of patients achieving a binocular CDVA of 20/25 or better. These results are similar to those recently reported by Marques and Ferreira (25) (0.08 ± 0.12 and 0.04 ± 0.10 logMAR, respectively), who also found a postoperative CDVA of 0.1 logMAR or better (20/25) in all eyes (30 eyes) at 3 months. However, both our monocular UDVA and CDVA are slightly lower than those found by Mojzis et al (23) (-0.03 ± 0.09 and -0.05 ± 0.08 logMAR, respectively) and Law et al (24) (0.05 ± 0.07 and -0.02 ± 0.05 logMAR, respectively) in a sample of 30 patients (60 eyes) 6 months after bilateral implantation of the AT LISA tri 839MP IOL. Regarding near vision, we obtained monocular UNVA (0.17 ± 0.13 logMAR) and DCNVA (0.14 ± 0.12 logMAR) results at the last follow-up visit of the same magnitude or better than those reported in previous studies with the same trifocal IOL (22) (23) (24) (25) . Furthermore, our study found good outcomes of postoperative binocular UNVA (0.07 ± 0.11 logMAR) and DCNVA (0.06 ± 0.10 log-MAR), with 87% of patients achieving 0.1 logMAR or better DCNVA (20/25) at 40 cm, which are considered suitable to obtain a high level of spectacle independence. Note that although all studies evaluated the same IOL model, differences in factors such as sample size, patient characteristics, postoperative follow-up period, and VA testing may explain this difference in VA outcomes between the studies.
In the present study, both corrected and uncorrected VA for far and near vision were comparable to those previously reported after implantation of earlier bifocal IOLs (18, 26, 27) . This is consistent with findings in a recent comparative study by Mojzis et al (22) . They found that VA results for far and near vision were similar and significantly better with the AT LISA tri 839MP IOL, respectively, compared to those with its bifocal predecessor (AT LISA 801, Carl Zeiss Meditec). These results suggest, therefore, that the creation of a third intermediate focus does not involve a detriment in of the other 2 main foci, the far focus and the near focus.
Our study had good VA results for intermediate distance. Six months postoperatively, the mean binocular DCIVA was 0.07 ± 0.11 (>20/25), 0.09 ± 0.08 (>20/25), and 0.11 ± 0.11 logMAR (approximately 20/25) at 50 cm, 60 cm, and 70 cm, respectively. These results agree with those reported in previous studies assessing the same IOL (22) (23) (24) (25) . Marques and Ferreira (25) reported 0.13 ± 0.42 and 0.09 ± 0.04 logMAR UIVA and DCIVA (80 cm), respectively, at 3-month follow-up. Law et al (24) found in a sample of 30 patients who had bilateral implantation of this trifocal IOL a 3-month postoperative binocular DCIVA (70 cm) of 0.16 ± 0.07 logRAD. In a recent study, Mojzis et al (23) reported a monocular logMAR UIVA and CDIVA (66 cm) of 0.08 ± 0.10 and 0.08 ± 0.10, respectively, 6 months after IOL implantation. Moreover, they reported better visual outcomes at intermediate distances (66 and 80 cm) with the AT LISA tri 839MP IOL when compared with those provided by its bifocal predecessor (22) . Similarly as for far and near vision, differences in intermediate VA between the studies may be attributed to differences in sample size, patient characteristics, follow-up period, and distances used for VA testing. As expected, the introduction of an intermediate focus in the optic design of the IOL resulted in an improvement in intermediate vision over the earlier bifocal IOL models, without compromising distance or near performance. In this sense, the defocus curve showed 2 excellent peaks corresponding to the distance focus (0.00 D defocus) and the near focus (-2.00 D to -2.50 D defocus). The sharp drop in VA commonly obtained in the intermediate distance range with bifocal IOLs was not observed here, but there was a wide range of useful vision between distance and near foci. This finding is in accordance with the defocus curve reported by previous studies from a smaller sample of patients who had implantation of the same trifocal IOL (22) (23) (24) (25) .
Regarding contrast sensitivity, the 6-month postoperative mean values obtained under photopic conditions were consistent with those reported in previous series (22, 23) , and slightly higher than those recently reported by Marques and Ferreira (25) . Our study found a reduction of the mesopic contrast sensitivity values both with and without glare in relation to photopic conditions, with statistical significance at medium and high spatial frequencies. This trend agrees with contrast sensitivity changes previously reported in patients with bifocal IOLs (3, 4) . It should be taken into account that the optic design of the AT LISA tri 839MP IOL combines a central trifocal zone of 4.34-mm diameter with a bifocal zone on the periphery. Therefore, when luminance level is reduced, a larger pupil diameter is reached (Tab. I) and consequently, a higher weight of the effect of IOL peripheral zone may be observed. A recent study by Law et al (24) with the same IOL also showed lower values of monocular mesopic contrast sensitivity in relation to photopic conditions both measured with the Pelli-Robson chart, although the difference in this parameter did not reach statistical significance (p>0.05).
Multifocal IOLs are associated with photic phenomena (i.e., halos, glare, and positive dysphotopsia) as a result of creating multiple images with simultaneous focuses (17, 28) . Because the design of the AT LISA tri 839MP IOL has fewer rings on the surface compared to earlier multifocal IOLs (e.g., the AT LISA IOL has 28) and no sharp angles in the optical surface, less photic phenomena are expected. In the present study, patients were satisfied with the visual outcomes achieved, especially in performing intermediate distance tasks. No patients complained of disturbing phenomena after the surgical procedure. Our findings are in line with the low photic phenomena scores reported in the recent study by Marques and Ferreira (25) after implantation of this trifocal IOL.
In summary, the present study found that bilateral implantation of the AT LISA tri 839MP IOL provided stable and good high-contrast VA outcomes at distance and near, with a satisfactory range of intermediate vision. Distance contrast sensitivity was better under photopic conditions and comparable with mesopic lighting conditions at low spatial frequencies.
These good visual quality outcomes support the implantation of this trifocal IOL as an effective solution to reduce spectacle dependence after lensectomy, enabling patients to feel more comfortable in daily activities. Future studies should include a longer follow-up to assess the safety and stability of this surgical procedure.
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